Skip to main content

BridgeBio Pharma, Inc.

BBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001743881

In the last 90 days, BridgeBio Pharma, Inc. insiders filed 0 open-market purchases and 5 sales; 475 institutions reported holding it in 13F filings for Q2 2026, worth $14.4B in total; Viking Global Investors is the only superinvestor holding it.

13F holders, Q1 2025

Institutional positions in BridgeBio Pharma, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
304
+45 vs. Q4 2024
Shares held
186.4M
+10.4M (+5.9%) vs. Q4 2024
Total value
$6.45B
+$1.62B (+33.6%) vs. Q4 2024
New holders
74
120 more added
Sold out
29
79 more reduced

4 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 304 institutions
Q1 2021: 199 institutionsQ2 2021: 201 institutionsQ3 2021: 212 institutionsQ4 2021: 195 institutionsQ1 2022: 179 institutionsQ2 2022: 165 institutionsQ3 2022: 181 institutionsQ4 2022: 179 institutionsQ1 2023: 213 institutionsQ2 2023: 197 institutionsQ3 2023: 221 institutionsQ4 2023: 247 institutionsQ1 2024: 244 institutionsQ2 2024: 251 institutionsQ3 2024: 254 institutionsQ4 2024: 263 institutionsQ1 2025: 304 institutionsQ2 2025: 359 institutionsQ3 2025: 392 institutionsQ4 2025: 435 institutionsQ1 2026: 462 institutionsQ2 2026: 475 institutions
Value heldQ1 2025: $6.45B
Q1 2021: $8.69BQ2 2021: $8.70BQ3 2021: $6.56BQ4 2021: $2.37BQ1 2022: $1.45BQ2 2022: $1.28BQ3 2022: $1.44BQ4 2022: $1.10BQ1 2023: $2.53BQ2 2023: $2.58BQ3 2023: $4.24BQ4 2023: $6.69BQ1 2024: $5.31BQ2 2024: $4.43BQ3 2024: $4.39BQ4 2024: $4.85BQ1 2025: $6.45BQ2 2025: $8.15BQ3 2025: $9.62BQ4 2025: $14.4BQ1 2026: $14.4BQ2 2026: $14.4B
Institutions holding BBIO and their total value by quarter
QuarterHoldersValue
Q2 2026475$14.4B
Q1 2026462$14.4B
Q4 2025435$14.4B
Q3 2025392$9.62B
Q2 2025359$8.15B
Q1 2025304$6.45B
Q4 2024263$4.85B
Q3 2024254$4.39B
Q2 2024251$4.43B
Q1 2024244$5.31B
Q4 2023247$6.69B
Q3 2023221$4.24B
Q2 2023197$2.58B
Q1 2023213$2.53B
Q4 2022179$1.10B
Q3 2022181$1.44B
Q2 2022165$1.28B
Q1 2022179$1.45B
Q4 2021195$2.37B
Q3 2021212$6.56B
Q2 2021201$8.70B
Q1 2021199$8.69B

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding BridgeBio Pharma, Inc.; share changes are against Q4 2024.

Institutions holding BBIO in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.13,357,496$461.8M0.01%−352,150−2.6%Reduced
Vanguard Group Inc14,900,145$515.1M0.01%−177,770−1.2%Reduced
Kohlberg Kravis Roberts & Co. L.P.19,260,971$665.9M15.04%−6,000,000−23.8%Reduced
Viking Global Investors LPSuperinvestorViking Global Investors22,055,375$762.5M2.42%−3,065,616−12.2%Reduced
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)0$00.00%−1,023,950−100.0%Sold out
Alyeska Investment Group, L.P.0$00.00%−940,415−100.0%Sold out
Octagon Capital Advisors LP0$00.00%−441,600−100.0%Sold out
Board of Trustees of The Leland Stanford Junior University0$00.00%−331,283−100.0%Sold out
Jefferies Financial Group Inc.0$00.00%−185,000−100.0%Sold out
Lighthouse Investment Partners, LLC0$00.00%−125,000−100.0%Sold out
Cinctive Capital Management LP0$00.00%−114,202−100.0%Sold out
Edgestream Partners, L.P.0$00.00%−56,235−100.0%Sold out
Polar Asset Management Partners Inc.0$00.00%−46,900−100.0%Sold out
Crestline Management, LP0$00.00%−44,740−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−25,980−100.0%Sold out
Readystate Asset Management LP0$00.00%−24,582−100.0%Sold out
Algert Global LLC0$00.00%−23,600−100.0%Sold out
Caption Management, LLC0$00.00%−21,900−100.0%Sold out
Natixis0$00.00%−18,500−100.0%Sold out
Parallax Volatility Advisers, L.P.0$00.00%−15,629−100.0%Sold out
Simplex Trading, LLC0$00.00%−15,256−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−14,760−100.0%Sold out
Virtus ETF Advisers LLC0$00.00%−12,637−100.0%Sold out
Belvedere Trading LLC0$00.00%−11,316−100.0%Sold out
Omers Administration Corp0$00.00%−11,200−100.0%Sold out
Graham Capital Management, L.P.0$00.00%−4,725−100.0%Sold out
PEAK6 LLC0$00.00%−3,600−100.0%Sold out
Elequin Capital LP0$00.00%−303−100.0%Sold out
Exchange Traded Concepts, LLC0$00.00%−222−100.0%Sold out
Sound Income Strategies, LLC0$00.00%−100−100.0%Sold out
CI Private Wealth, LLC0$00.00%−19,259−100.0%Sold out
Colonial Trust Advisors0$00.00%−22−100.0%Sold out
PFG Private Wealth Management, LLC0$00.00%−11−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed
Fernwood Investment Management, LLC––––Not filed
EPIQ Capital Group, LLC––––Not filed
Global Retirement Partners, LLC––––Not filed